The use oforal non-steroidal anti-inflammatory drugs (NSAIDs) in 31 patients with collagenous colitis and in 31 matched control patients with irritable bowel syndrome or colonic diverticular disease who had also undergone colonoscopy and biopsy was investigated. The long term use (>6 months) of NSAIDs was significantly commoner in the study group (19/31) than in the control group (4/31) (p<002), even assuming the most adverse drug history in six patients in whom this could not be established. In all patients with collagenous colitis taking NSAIDs, diarrhoea followed the use of these drugs, and by a mean (SD) of 5.5 (4.4) years (range 05 to 15 years). In three patients with collagenous colitis, diarrhoea improved after withdrawing NSAIDs; rechallenge in one was followed by a recurrence of diarrhoea, which improved after withdrawing the drug again. It is suggested that NSAIDs may play an aetiological role in the diarrhoea and thickened coliagen band in some patients with collagenous colitis.
Collagenous colitis is an uncommon condition that affects the large bowel, primarily in middle aged and elderly women, and is characterised clinically by watery diarrhoea and histologically by thickening of the subepithelial collagen band with chronic inflammation. Its aetiology is still unclear, although a variety of associated diseases have been reported including not only gastrointestinal diseases such as coeliac disease,' 2 collagenous sprue, 3 and enterovirus infection4 but also systemic diseases such as rheumatic syndromes,5'8 scleroderma,5 gout,6 7 and thyroid diseases. 6 Two patients with collagenous colitis in whom there was prior use of non-steroidal anti-inflammatory drugs (NSAIDs) and antibiotics have been reported,7 and we have noted a similar association with NSAIDs in many of our patients. One report raised the question of an association with caffeine,9 which can cause an increase in the fluid load to the colon. '0 In view of the association with many different types of arthritis, NSAIDs could theoretically be expected to be used more frequently in patients with collagenous colitis. Some of our patients seemed to benefit symptomatically from withdrawal of medications which included NSAIDs. We therefore wondered ifthe association between this disorder and NSAID use was more than coincidental because of their use in arthritis associated with collagenous colitis. This study aimed to investigate whether there is a causal relationship between collagenous colitis and NSAID use in our patients, and if so the nature of the temporal relationship between the onset of diarrhoea and the use of NSAIDs, the type of NSAID used together with the time for which it had been used, and whether any patient responded to withdrawal or rechallenge. tYears of ingestion before the biopsy.
Methods
Superscript a-f: each represents the same patient; further details of the drug sequence in these patients are provided in Figure. able. Statistical analysis showed that NSAID use was significantly more prevalent in patients with collagenous colitis than in control patients (p<002), even though we assumed that the most adverse drug history was present in the six patients with an unclear drug history -that is that the two patients in the collagenous colitis group had not been taking NSAIDs and the four in the control group had been taking them. Had these simply been excluded the p value would have been <0 0005 using Fisher's exact probability test. Both daily dosage and total dosage varied markedly (Table) . Temporal relationship ofNSAID ingestion in patients who had a complicated drug history, a relationship between withdrawal and cessation ofdiarrhoea (a, f, h), rechallenge (h), and demonstration that change in the type ofdrug had no effect on symptoms (f, g). '9 NSAIDs are also well recognised causes of both small and large bowel ulcers, with or without perforation.22`30 The mechanism may be different, but this provides supporting evidence that NSAIDs can affect the large as well as the small bowel. Small bowel ulceration may heal with multiple areas of stenosis (diaphragm disease),2"022 but this has not been reported in the large bowel, nor is it clear whether these patients are predisposed to 'microscopic colitis' or collagenous colitis.
The mechanism by which NSAIDs cause colitis and subepithelial collagen band thickening remains unclear. However, injected "'Indium labelled neutrophils localise to the terminal ileum in up to two thirds of patients with rheumatoid arthritis on long term NSAIDs but not in untreated patients, and this finding is accompanied by an increase in intestinal permeability demonstrated by an excess absorption of 5'Cr-EDTA (ethylenediaminetetra acetic acid).2""2 Although one study26 has suggested a possible primary role of rheumatoid arthritis in the intestinal inflammation, another study using healthy volunteers has shown that intestinal permeability after NSAID ingestion increases significantly compared with control values.27 In addition, normal intestinal absorption ofEDTA, which is absorbed primarily through the paracellular pathway rather than across the cell, can be greatly reduced by coadministration of a prostaglandin analogue (misoprostol).28 Prostaglandin is also thought to be able to prevent indomethacin induced small intestinal inflammation.2930 It is therefore possible in some patients that in the large bowel as well as the small, NSAIDs open the paracellular pathway at least sufficiently for the luminal contents to enter the lamina propria, thereby inducing mucosal inflammation. Although this is also the site of collagen band thickening, the mechanism by which this occurs remains obscure. Local abnormalities ofcollagen synthesis related to the pericryptal fibloblastic sheath and decreased cell turnover time have been considered as another possible mechanism of collagen band thickening.2 83 32 Because 12 patients with collagenous colitis had no history of NSAID use, there may be a variety of aetiological factors in this disease.
Other have reported an association with coeliac disease,' 2 collagenous sprue,3 or caffeine use.9 In our series two patients also had coeliac disease, but neither was taking NSAIDs. Because diarrhoea in both patients failed to respond fully to a gluten free diet but their symptoms were controlled by other means, we doubt that gluten is involved in the mechanism ofcollagenous colitis.
An intriguing factor in respect of this hypothesis is the long latent interval between the start of NSAID use and the development of symptoms. Assuming that the data are reason-ably accurate, the mean was more than five years but in some patients reached 15 years. If a relationship existed with NSAIDs, we expected that it would have been dependent on the dose used or the length of time the drugs had been taken. However, the Table shows that while the disease certainly occurred in patients taking high doses ofNSAIDs, it also occurred in those taking relatively small amounts for short periods of time. In view of the relative rarity of collagenous colitis in a population in whom about 10% may be taking NSAIDs, this seems to be a rare complication and may simply reflect an unfortunate individual idiosyncratic sensitivity to the drug. More probably, collagenous colitis is a multistep disease, in which inflammation caused by NSAIDs sets the stage for a further, as yet undetermined, insult that precipitates the disease. Fortuitously, our minimum length of time that could be accepted as long term NSAID use (six months) is also the minimum interval between the onset of diarrhoea following the use of NSAIDs. The possibility that some patients taking NSAIDs more than just occasionally could have been excluded because NSAID use was less than six months was investigated by reviewing all the data again: this did not seem to have been the case. The total cumulative dose of NSAIDs could also be important. However, the fact that our patient 'C' required six months of treatment on both occasions, and stopped for nine months only suggests that if this is the case any cumulative effect is lost rapidly after stopping the drugs.
It is unclear how representative our small control group is of the general population, particularly with regard to their use of NSAIDs. In our control group, 4 of 31 patients (13%) were taking NSAIDs. This is similar to the figure obtained by Langman, et al'8 in their study in which 8% of their 268 control patients aged over 40 and 10% of those aged over 60 were also taking NSAIDs. Our control group is therefore likely to be reasonably representative of the general population, and the prevalence of NSAID ingestion is unlikely to be artificially low.
In conclusion, this study suggests that NSAIDs may be an aetiological factor in collagenous colitis in a major subgroup of patients (61% in this study) with this disease. Patients taking NSAIDs therefore may warrant investigation for collagenous colitis if they develop watery diarrhoea. When diagnosed as having the disease, stopping NSAIDs should be considered. However, in view of the frequency with which NSAIDs are taken long term in the general population, this is probably an uncommon complication.
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